These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10604951)

  • 41. Nefiracetam potentiates N-methyl-D-aspartate (NMDA) receptor function via protein kinase C activation and reduces magnesium block of NMDA receptor.
    Moriguchi S; Shioda N; Maejima H; Zhao X; Marszalec W; Yeh JZ; Fukunaga K; Narahashi T
    Mol Pharmacol; 2007 Feb; 71(2):580-7. PubMed ID: 17095583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function.
    Madry C; Mesic I; Bartholomäus I; Nicke A; Betz H; Laube B
    Biochem Biophys Res Commun; 2007 Mar; 354(1):102-8. PubMed ID: 17214961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific inhibition of N-methyl-D-aspartate receptor function in rat hippocampal neurons by L-phenylalanine at concentrations observed during phenylketonuria.
    Glushakov AV; Dennis DM; Morey TE; Sumners C; Cucchiara RF; Seubert CN; Martynyuk AE
    Mol Psychiatry; 2002; 7(4):359-67. PubMed ID: 11986979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channels.
    Maillard MC; Perlman ME; Amitay O; Baxter D; Berlove D; Connaughton S; Fischer JB; Guo JQ; Hu LY; McBurney RN; Nagy PI; Subbarao K; Yost EA; Zhang L; Durant GJ
    J Med Chem; 1998 Jul; 41(16):3048-61. PubMed ID: 9685245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects on ethanol withdrawal hyperexcitability of chronic treatment with a competitive N-methyl-D-aspartate receptor antagonist.
    Ripley TL; Little HJ
    J Pharmacol Exp Ther; 1995 Jan; 272(1):112-8. PubMed ID: 7815323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. (E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists.
    Balsamini C; Bedini A; Diamantini G; Spadoni G; Tontini A; Tarzia G; Di Fabio R; Feriani A; Reggiani A; Tedesco G; Valigi R
    J Med Chem; 1998 Mar; 41(6):808-20. PubMed ID: 9526557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CGS 19755: a novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic properties.
    Bennett DA; Lehmann J; Bernard PS; Liebman JM; Williams M; Wood PL; Boast CA; Hutchison AJ
    Prog Clin Biol Res; 1990; 361():519-24. PubMed ID: 1981269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain.
    Tabakoff B; Ren W; Vanderlinden L; Snell LD; Matheson CJ; Wang ZJ; Levinson R; Smothers CT; Woodward JJ; Honse Y; Lovinger D; Rush AM; Sather WA; Gustafson DL; Hoffman PL
    Eur J Pharmacol; 2016 Aug; 784():1-14. PubMed ID: 27158117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles.
    Kehne JH; Baron BM; Harrison BL; McCloskey TC; Palfreyman MG; Poirot M; Salituro FG; Siegel BW; Slone AL; Van Giersbergen PL
    Eur J Pharmacol; 1995 Sep; 284(1-2):109-18. PubMed ID: 8549613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antagonists of ionotropic glutamate receptors as the object of research in psychopharmacology].
    Bespalov AIu; Evartau EE
    Usp Fiziol Nauk; 1999; 30(1):39-53. PubMed ID: 10205818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel N-methyl-D-aspartate receptor open channel blocker with in vivo neuroprotectant activity.
    Planells-Cases R; Montoliu C; Humet M; Fernández AM; García-Martínez C; Valera E; Merino JM; Pérez-Payá E; Messeguer A; Felipo V; Ferrer-Montiel A
    J Pharmacol Exp Ther; 2002 Jul; 302(1):163-73. PubMed ID: 12065713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strychnine-insensitive glycine/NMDA sites are altered in two stress models of depression.
    Nowak G; Ossowska G; Jopek R; Papp M
    Pol J Pharmacol; 1998; 50(4-5):365-9. PubMed ID: 10091723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The contribution of voltage-gated and NMDA receptor-gated calcium channels to ethanol withdrawal seizures.
    Hoffman PL; Tabakoff B
    Alcohol Alcohol Suppl; 1991; 1():171-5. PubMed ID: 1669005
    [No Abstract]   [Full Text] [Related]  

  • 55. 3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site.
    Salituro FG; Harrison BL; Baron BM; Nyce PL; Stewart KT; Kehne JH; White HS; McDonald IA
    J Med Chem; 1992 May; 35(10):1791-9. PubMed ID: 1534125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 4-[(Carboxymethyl)oxy]- and 4-[(carboxymethyl)amino]-5,7-dichloroquinoline-2-carboxylic acid: new antagonists of the strychnine-insensitive glycine binding site on the N-methyl-D-aspartate receptor complex.
    Harrison BL; Baron BM; Cousino DM; McDonald IA
    J Med Chem; 1990 Dec; 33(12):3130-2. PubMed ID: 2147957
    [No Abstract]   [Full Text] [Related]  

  • 57. LY233053: a structurally novel, potent and selective competitive N-methyl-D-aspartate receptor antagonist.
    Ornstein PL; Schoepp DD; Leander JD; Wong T; Zimmerman DM; Lodge D
    Prog Clin Biol Res; 1990; 361():429-33. PubMed ID: 2149764
    [No Abstract]   [Full Text] [Related]  

  • 58. Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterization.
    Conti P; Pinto A; Tamborini L; Madsen U; Nielsen B; Bräuner-Osborne H; Hansen KB; Landucci E; Pellegrini-Giampietro DE; De Sarro G; Donato Di Paola E; De Micheli C
    ChemMedChem; 2010 Sep; 5(9):1465-75. PubMed ID: 20665761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Manganese poisoning reduces strychnine-insensitive glycine binding sites in the globus pallidus of the mouse brain.
    Cano G; Suárez-Roca H; Bonilla E
    Invest Clin; 1996 Dec; 37(4):209-19. PubMed ID: 8968129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polyamine-like actions of aminoglycosides at recombinant N-methyl-D-aspartate receptors.
    Harvey SC; Skolnick P
    J Pharmacol Exp Ther; 1999 Oct; 291(1):285-91. PubMed ID: 10490915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.